Open access
Oct 2026
Tissue galectin-3 as a potential prognostic biomarker in type 2 diabetes patients with hepatocellular carcinoma: in vitro and in silico approaches
Type 2 diabetes (T2D) is a chronic metabolic disorder characterized by hyperglycemia, generating circulating glycated albumin (GA). The development and progression of liver cancer, and more specifically hepatocellular carcinoma (HCC), are increased in patients with T2D. To facilitate early diagnosis and appropriate...
Sabine Matou-Nasri, Amina Munye, Hamad Al-Eidi et al.
· Scientific Reports · 0 citations